Terazosin hydrochloride and Hyperlipidaemia - a phase IV clinical study of FDA data
Summary:
Hyperlipidaemia is reported as a side effect among people who take Terazosin hydrochloride (terazosin hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Aspirin, and have Gait disturbance.
The phase IV clinical study analyzes which people have Hyperlipidaemia when taking Terazosin hydrochloride. It is created by eHealthMe based on reports of 1,857 people who have side effects when taking Terazosin hydrochloride from the FDA, and is updated regularly.
What is Terazosin hydrochloride?
Terazosin hydrochloride has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 2,352 Terazosin hydrochloride users. Check the latest studies of Terazosin hydrochloride.
What is Hyperlipidaemia?
Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,419 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,857 people reported to have side effects when taking Terazosin hydrochloride.
Among them, 12 people (0.65%) have Hyperlipidaemia.

Among these 12 people:
How long have people been on Terazosin hydrochloride when they have Hyperlipidaemia? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hyperlipidaemia when taking Terazosin hydrochloride? *
- female: 8.33 %
- male: 91.67 %
What is the age of people who have Hyperlipidaemia when taking Terazosin hydrochloride? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 11.11 %
- 50-59: 66.67 %
- 60+: 22.22 %
What are other drugs people take besides Terazosin hydrochloride? *
- Aspirin: 6 people, 50.00%
- Revatio: 5 people, 41.67%
- Advil: 5 people, 41.67%
- Tysabri: 5 people, 41.67%
- Vitamin D3: 5 people, 41.67%
- Ampyra: 5 people, 41.67%
- Aredia: 4 people, 33.33%
- Belsomra: 4 people, 33.33%
- Zometa: 4 people, 33.33%
- Allopurinol: 4 people, 33.33%
What are other side effects people have besides Hyperlipidaemia? *
- Dizziness: 9 people, 75.00%
- Dyspnea (difficult or laboured breathing): 9 people, 75.00%
- Stress And Anxiety: 9 people, 75.00%
- Tenderness (pain or discomfort when an affected area is touched): 8 people, 66.67%
- Hearing Loss: 8 people, 66.67%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 8 people, 66.67%
- Gait Disturbance: 8 people, 66.67%
- Hypoaesthesia (reduced sense of touch or sensation): 8 people, 66.67%
- Constipation: 8 people, 66.67%
- Neuralgia (pain in one or more nerves): 8 people, 66.67%
What are the existing conditions these people have? *
- Gait Disturbance: 5 people, 41.67%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 33.33%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 33.33%
- Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 3 people, 25.00%
- Movement - Uncoordinated: 2 people, 16.67%
- Sleep Disorder: 1 person, 8.33%
- Pancreatitis Chronic (chronic inflammation of pancreas): 1 person, 8.33%
- Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 1 person, 8.33%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
- Micturition Disorder (disease of passing urine): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Terazosin hydrochloride and have Hyperlipidaemia?
- Check whether Hyperlipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Terazosin hydrochloride:
- Terazosin hydrochloride (2,352 reports)
Hyperlipidaemia treatments and more:
- Hyperlipidaemia (86,394 reports)
How severe was Hyperlipidaemia and when was it recovered:
Expand to all the drugs that have ingredients of terazosin hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Terazosin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperlipidaemia:
- Hyperlipidaemia (1,419 drugs)
Browse all the conditions that are associated with Hyperlipidaemia:
- Hyperlipidaemia (1,410 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on terazosin hydrochloride (the active ingredients of Terazosin hydrochloride) and Terazosin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Invega and Reglan - now
- Drug interactions of Sonata and Klonopin - 3 seconds ago
- Could Reyataz cause Post-Traumatic Stress Disorder? - 4 seconds ago
- Could Reyataz cause Post Traumatic Stress Disorder? - 4 seconds ago
- Could Fluorouracil cause Right Atrial Dilatation? - 8 seconds ago
- Drug interactions of Lisinopril and Alginate - 10 seconds ago
- Could Metronidazole cause Salivary Gland Infections? - 23 seconds ago
- Hydrochlorothiazide vs. Hydroxyzine Pamoate, side effect and effectiveness comparison - 28 seconds ago
- Could Midazolam Hydrochloride cause Mitral Valve Incompetence? - 30 seconds ago
- Could Azacitidine cause Injection Site Reaction? - 35 seconds ago